As a pioneer in Pakistan, Bio-Labs will start production this month of the antiviral drug Remdesivir, which has shown promise in fighting COVID 19 and has recently been approved by US FDA for the respiratory disease caused by the coronavirus. Remdesivir shall be available as a 100mg injection lyophilised via manufacturing process as per innovator specifications.
Bio-Labs remains committed to innovating therapeutic products for a healthier society.